Prediction Case File
YouTubeEvaluation Complete

UnitedHealth stock is popping on the back of positive developments.

1 extracted signal · 1 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFAIndependent analyst profile
Source published
10 Sept 2025, 21:51 UTC
Recorded by Tahlil Plus
18 May 2026, 20:23 UTC
Video preview for UnitedHealth stock is popping on the back of positive developments.
Source overview

AI-generated source summary

The analysis reviews UnitedHealth Group's (UNH) recent stock performance and the news driving a nearly 9% increase in share price. The positive catalyst is the high percentage of Medicare Advantage enrollees qualifying for bonus payments from the federal government. This offsets earlier concerns regarding underestimated costs for serving Medicare Advantage customers. The analyst mentions that after adjusting numbers following this announcement, his intrinsic value per share target for UNH is $450.69, indicating continued undervaluation and reiterating a buy recommendation. Mention the 52 week low that was $234.60.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
1
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
100%
1 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

Parkev Tatevosian, CFA

Platform-wide history, separate from this source evaluation.

Reliability
41.8
Tracked signals
1293
Historical success
25.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail